Aryl hydrocarbon receptor null mice develop cardiac hypertrophy and increased hypoxia-inducible factor-1α in the absence of cardiac hypoxia

Cardiovascular Toxicology

Volumn 2, Issue 4, 2002, Pages 263-273

  Thackaberry, E A ^b   Gabaldon, D M ^b   Walker, M K ^b   Smith, S M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Aryl hydrocarbon receptor; Cardiac hypertrophy; Hypoxia; Hypoxia inducible factor 1 ; Vascular endothelial growth factor

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DIMERIZATION; GENE EXPRESSION REGULATION; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HYPOXIA; IN VIVO STUDY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

AGE FACTORS; ANIMALS; ANOXIA; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BODY WEIGHT; CARDIAC MYOSINS; CARDIOMEGALY; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; GENE EXPRESSION REGULATION; HEART VENTRICLES; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, MUTANT STRAINS; MODELS, CARDIOVASCULAR; MYOCARDIUM; MYOSIN HEAVY CHAINS; MYOSIN LIGHT CHAINS; NONMUSCLE MYOSIN TYPE IIB; ORGAN SIZE; PHENOTYPE; RATS; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS; TIME FACTORS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; VERTEBRATA;

EID: 0042027544     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:2:4:263     Document Type: Article

References (40)

1. Burbach, K.M., Poland, A., and Bradfield, C.A. (1992). Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. USA 89:8185-8189.
2. Wang, G.L. and Semenza, G.L. (1993). Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268:21,513-21,518.
3. Denison, M.S., Fisher, J.M., and Whitlock, J.P., Jr. (1988). The DNA recognition site for the dioxin-Ah receptor complex. Nucleotide sequence and functional analysis. J. Biol. Chem. 263:17,221-17,224.
4. Fernandez-Salguero, P.M., Ward, J.M., Sundberg, J.P., and Gonzalez, F.J. (1997). Lesions of aryl-hydrocarbon receptor-deficient mice. Vet. Pathol. 34:605-614.
5. Walker, M.K., Pollenz, R.S., and Smith, S.M. (1997). Expression of the aryl hydrocarbon receptor (AhR) and AhR nuclear translocator during chick cardiogenesis is consistent with 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced heart defects. Toxicol. Appl. Pharmacol. 143:407-419.
6. Guiney, P.D., Walker, M.K., Spitsbergen, J.M., and Peterson, R.E. (2000). Hemodynamic dysfunction and cytochrome P4501A mRNA expression induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin during embryonic stages of lake trout development. Toxicol. Appl. Pharmacol. 168:1-14.
7. Lin, T.M., Ko, K., Moore, R.W., Buchanan, D.L., Cooke, P.S., and Peterson, R.E. (2001). Role of the aryl hydrocarbon receptor in the development of control and 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed male mice. J. Toxicol. Environ. Health A 64:327-342.
8. Lahvis, G.P., Lindell, S.L., Thomas, R.S., et al. (2000). Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc. Natl. Acad. Sci. USA 97:10,442-10,447.
9. Lee, S.H., Wolf, P.L., Escudero, R., Deutsch, R., Jamieson, S.W., and Thistlethwaite, P.A. (2000). Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 342:626-633.
10. Tomanek, R.J., Schalk, K.A., Marcus, M.L., and Harrison, D.G. (1989). Coronary angiogenesis during long-term hypertension and left ventricular hypertrophy in dogs. Circ. Res. 65:352-359.
11. Ashruf, J.F., Ince, C., and Bruining, H.A. (1999). Regional ischemia in hypertrophic Langendorff-perfused rat hearts. Am. J. Physiol. 277:H1532-H1539.
12. Martin, G.V., Caldwell, J.H., Rasey, J.S., Grunbaum, Z., Cerqueira, M., and Krohn, K.A. (1989). Enhanced binding of the hypoxic cell marker [3H]fluoromisonidazole in ischemic myocardium. J. Nucl. Med. 30:194-201.
13. Semenza, G.L., Jiang, B.H., Leung, S.W., et al. (1996). Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271:32,529-32,537.
14. Forsythe, J.A., Jiang, B.H., Iyer, N.V., et al. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604-4613.
15. Hu, J., Discher, D.J., Bishopric, N.H., and Webster, K.A. (1998). Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem. Biophys. Res. Commun. 245:894-899.
16. Yue, X. and Tomanek, R.J. (1999). Stimulation of coronary vasculogenesis/angiogenesis by hypoxia in cultured embryonic hearts. Dev. Dynam. 216:28-36.
17. Matsunaga, T., Warltier, D.C., Weihrauch, D.W., Moniz, M., Tessmer, J., Chilian, W.M. (2002). Ischemia-induced coronary collateral growth is dependant on vascular endothelial growth factor and nitric oxide. Circulation 102, 3098-3103.
18. Ito, H., Adachi, S., Tamamori, M., et al. (1996). Mild hypoxia induces hypertrophy of cultured neonatal rat cardiomyocytes: a possible endogenous endothelin-1-mediated mechanism. J. Mol. Cell. Cardiol. 28:1271-1277.
19. Martin, C., Yu, A.Y., Jiang, B.H., et al. (1998). Cardiac hypertrophy in chronically anemic fetal sheep: increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am. J. Obstet. Gynecol. 178:527-534.
20. Vanden Heuvel, J.P., Tyson, F.L., and Bell, D.A. (1993). Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. Biotechniques 14:395-398.
21. Halder, J.B., Zhao, X., Soker, S., et al. (2000). Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation. Genesis: J. Gen. Dev. 26:213-224.
22. 2? Biochem. Pharmacol. 36:3487-3494.
23. Frohlich, E.D., Apstein, C., Chobanian, A.V., et al. (1992). The heart in hypertension. N. Engl. J. Med. 327:998-1008.
24. Mercadier, J.J., Samuel, J.L., Michel, J.B., et al. (1989). Atrial natriuretic factor gene expression in rat ventricle during experimental hypertension. Am. J. Physiol. 257:H979-H987.
25. Lee, H.R., Henderson, S.A., Reynolds, R., Dunnmon, P., Yuan, D., and Chien, K.R. (1988). Alpha 1-adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells. Effects on myosin light chain-2 gene expression. J. Biol. Chem. 263:7352-7358.
26. Park, H.K., Park, S.J., Kim, C.S., Paek, Y.W., Lee, J.U., and Lee, W.J. (2001). Enhanced gene expression of reninangiotensin system, TGF-beta1, endothelin-1 and nitric oxide synthase in right-ventricular hypertrophy. Pharmacol. Res. 43:265-273.
27. Brogi, E., Wu, T., Namiki, A., and Isner, J.M. (1994). Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90:649-652.
28. Frank, S., Hubner, G., Breier, G., Longaker, M.T., Greenhalgh, D.G., and Werner, S. (1995). Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J. Biol. Chem. 270:12,607-12,613.
29. McAinsh, A.M., Geyer, M., Fandrey, J., Ruegg, J.C., and Wiesner, R.J. (1998). Expression of vascular endothelial growth factor during the development of cardiac hypertrophy in spontaneously hypertensive rats. Mol. Cell. Biochem, 187:141-146.
30. Richard, D.E., Berra, E., and Pouyssegur, J. (2000). Non-hypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem. 275:26,765-26,771.
31. Zelzer, E., Levy, Y., Kahana, C., Shilo, B.Z., Rubinstein, M., and Cohen, B. (1998). Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J. 17:5085-5094.
32. Park, H. (1999). Aromatic hydrocarbon nuclear translocator as a common component for the hypoxia- and dioxin-induced gene expression. Mol. Cells 9:172-178.
33. Lees, M.J. and Whitelaw, M.L. (1999). Multiple roles of ligand in transforming the dioxin receptor to an active basic helix-loop-helix/PAS transcription factor complex with the nuclear protein Amt. Mol. Cell. Biol. 19:5811-5822.
34. Heid, S.E., Pollenz, R.S., and Swanson, H.I. (2000). Role of heat shock protein 90 dissociation in mediating agonist-induced activation of the aryl hydrocarbon receptor. Mol. Pharmacol. 57:82-92.
35. Chan, W.K., Yao, G., Gu, Y.Z., and Bradfield, C.A. (1999). Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstration of competition and compensation. J. Biol. Chem. 274:12,115-12,123.
36. Pollenz, R.S., Davarinos, N.A., and Shearer, T.P. (1999). Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor. Mol. Pharmacol. 56:1127-1137.
37. Tomita, S., Sinal, C.J., Yim, S.H., and Gonzalez, F.J. (2000). Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1alpha. Mol. Endocrinol. 14:1674-1681.
38. Kuil, C.W., Brouwer, A., van der Saag, P.T., and van der Burg, B. (1998). Interference between progesterone and dioxin signal transduction pathways. Different mechanisms are involved in repression by the progesterone receptor A and B isofonns. J. Biol. Chem. 273:8829-8834.
39. Womlke, M., Stoner, M., Saville, B., and Safe, S. (2000). Crosstalk between estrogen receptor alpha and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes. FEBS Lett. 478:109-112.
40. Lund, A.K., Kanagy, N.L., and Walker, M.K. (2002). Aryl hydrocarbon receptor (AhR) null mice exhibit hypertension and increased plasma endothelin levels. Toxicol. Sci. 66:8.